|
|
| Research article summary (published 13 Mar 2006): |
Expression of PTEN, p27, p21 and AKT mRNA and protein in human BEL-7402 hepatocarcinoma cells in transplanted tumors of nude mice treated with the tripeptide tyroservatide (YSV).
Full Abstract
The tripeptide, tyroservatide (YSV), has been previously shown to have antitumor effects through unknown mechanism. In the current study, we examined whether YSV modulates the protumorigenic PI3K pathway in human BEL-7402 hepatocarcinoma cells. BEL-7402 hepatocarcinoma was transplanted into the subcutaneous tissues of nude mice, and YSV, at varying doses, was administered. RT-PCR and Western blot were used to analyze the expression of PTEN, AKT, p21 and p27. YSV at doses of 80 microg/kg/day, 160 microg/kg/day and 320 microg/kg/day markedly inhibited the growth of human BEL-7402 hepatocarcinoma (p < 0.05). YSV increased mRNA and protein expression of the tumor-suppressor genes, PTEN, p21 and p27, and inhibited the mRNA and protein expression of the oncogene AKT. Furthermore, YSV administration was associated with dephosphorylation of both PTEN (which activates PTEN) and AKT (which inhibits AKT). These results are consistent with the possibility that YSV mediates inhibition of tumor growth through inhibition of the PI3K pathway and suggests that YSV should be explored for use as an antitumor agent for hepatocarcinoma.
Author information
Author/s: Zhu, Zhitong (Z); Jia, Jing (J); Lu, Rong (R); Lu, Yi (Y); Fu, Zheng (Z); Zhao, Lan (L); Wang, Li (L); Jin, Mengjue (M); Zhao, Lin (L); Gao, Wenyuan (W); Yao, Zhi (Z);
Affiliation: Department of Immunology, Tianjin Medical University, Tianjin 300070, China.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: International journal of cancer. Journal international du cancer (Int J Cancer), published in United States. (Language: eng)
Reference: 2006-Mar; vol 118 (issue 6) : pp 1539-44
Dates: Created 2006/01/24; Completed 2007/05/29; Revised 2007/07/24;
PMID: 16184552, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Cyclin-Dependent Kinase Inhibitor p21 (0) ; Intracellular Signaling Peptides and Proteins (0) ; Oligopeptides (0) ; RNA, Messenger (0) ; tripeptide tyroservatide (0) ; Cyclin-Dependent Kinase Inhibitor p27 (147604-94-2) ; Proto-Oncogene Proteins c-akt (EC 2.7.1.37) ; PTEN Phosphohydrolase (EC 3.1.3.67)Related articles
These are the most related articles currently in our database:
- [Expression and significance of Ser10 phosphorylated p27(kip1) and JAB1 protein in human hepatocellular carcinoma]
29 Nov 2007 - Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.
20 Oct 2007 - Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402.
21 Sep 2005 - Construction of the recombinant adenovirus vector carrying antisense multidrug resistance gene.
30 Jan 2006 - Gene induction and apoptosis in human hepatocellular carci-noma cells SMMC-7721 exposed to 5-aza-2'-deoxycytidine.
18 Sep 2007 - Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control.
30 Aug 2002 - Inhibition of human hepatocellular carcinoma by L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vitro and in vivo.
30 Oct 2004 - PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404.
5 Aug 2006 - Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma.
30 May 2002 - The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
29 Nov 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.